Steven R. Grossman
Affiliations: | Virginia Commonwealth University School of Medicine, Richmond, VA |
Google:
"Steven Grossman"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chougoni KK, Park H, Damle PK, et al. (2023) Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma. Oncogenesis. 12: 53 |
| Dcona MM, Chougoni KK, Dcona DT, et al. (2023) Combined targeting of NAD biosynthesis and the NAD-dependent transcription factor C-terminal Binding Protein as a promising novel therapy for pancreatic cancer. Cancer Research Communications |
| Zhang T, Li S, Tan YA, et al. (2023) Bcl-xL is translocated to the nucleus via CtBP2 to epigenetically promote metastasis. Biorxiv : the Preprint Server For Biology |
| Jecrois AM, Dcona MM, Deng X, et al. (2020) Cryo-EM Structure of CtBP2 Confirms Tetrameric Architecture. Structure (London, England : 1993) |
| Ding B, Yuan F, Damle PK, et al. (2020) CtBP determines ovarian cancer cell fate through repression of death receptors. Cell Death & Disease. 11: 286 |
| Oduah EI, Grossman SR. (2020) Harnessing the vulnerabilities of p53 mutants in lung cancer - Focusing on the proteasome: a new trick for an old foe? Cancer Biology & Therapy. 1-10 |
| Adashek JJ, Szeto C, Sanborn JZ, et al. (2020) Targetable immune checkpoint molecules may be significantly differentially expressed in minority ethnicities. Journal of Clinical Oncology. 38: 3576-3576 |
| Yazbeck V, McConnell I, Harris E, et al. (2020) Abstract B41: Modeling marginal zone lymphomagenesis Cancer Research. 80 |
| Ding B, Haidurov A, Chawla A, et al. (2019) p53-inducible SESTRINs might play opposite roles in the regulation of early and late stages of lung carcinogenesis. Oncotarget. 10: 6997-7009 |
| Dcona MM, Damle PK, Zarate-Perez F, et al. (2019) Active-site tryptophan, the target of anti-neoplastic CtBP inhibitors, mediates inhibitor disruption of CtBP oligomerization and transcription coregulatory activities. Molecular Pharmacology |